Kyle Griffin @kylegriffin1
The Trump admin's effort to rapidly launch a U.S. manufacturer for drugs to treat coronavirus patients hinges on a new company whose chief executive is best known for a failed anti-allergy injector and for raising the prices of a powerful opioid antidote. https://t.co/DbHg85N9Zp — PolitiTweet.org